Company Description
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering.
The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials.
The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys.
The Wellspect Healthcare segment offers intermittent urinary catheters under the LoFric brand and irrigation systems under the Navina brand.
The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016.
DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
| Country | United States |
| Founded | 1899 |
| IPO Date | Aug 12, 1987 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 14,000 |
| CEO | Simon Campion |
Contact Details
Address: 13320 Ballantyne Corporate Place Charlotte, North Carolina 28277-3607 United States | |
| Phone | 844 848 0137 |
| Website | dentsplysirona.com |
Stock Details
| Ticker Symbol | XRAY |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000818479 |
| CUSIP Number | 24906P109 |
| ISIN Number | US24906P1093 |
| Employer ID | 39-1434669 |
| SIC Code | 3843 |
Key Executives
| Name | Position |
|---|---|
| Simon D. Campion | Chief Executive Officer, President and Director |
| Richard C. Rosenzweig J.D. | Executive Vice President of Corporate Development, General Counsel and Secretary |
| Robert Anthony Johnson | Senior Vice President and Chief Supply Chain Officer and Head of Sustainability |
| Herman V. Cueto | Interim Chief Financial Officer |
| Kevin J. Czerney | Vice President and Chief Accounting Officer |
| Kevin Boyle | Senior Vice President and Chief Technology Officer |
| Andrea Daley | Vice President of Investor Relations |
| Andrea L. Frohning | Senior Vice President and Chief Human Resources Officer |
| Emily P. Miner | Senior Vice President of Global Quality and Regulatory and Chief Quality Officer |
| David Ferguson | Senior Vice President of Global Business Unit Leader |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 14, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 9, 2025 | ARS | Filing |
| Apr 9, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 9, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 31, 2025 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
| Mar 19, 2025 | 8-K | Current Report |
| Feb 27, 2025 | 10-K | Annual Report |
| Feb 27, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 11, 2025 | SCHEDULE 13G | Filing |